Exploiting alloreactivity for tumour immunotherapy

Vox Sang. 2004 Jul:87 Suppl 2:227-9. doi: 10.1111/j.1741-6892.2004.00493.x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Graft vs Host Disease / immunology
  • Humans
  • Immunotherapy / methods*
  • Neoplasms / therapy*
  • Receptors, Antigen, T-Cell / metabolism
  • T-Lymphocytes / immunology*
  • T-Lymphocytes, Cytotoxic / immunology

Substances

  • Receptors, Antigen, T-Cell